{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-097471","form_type":"8-K","ticker":"RBOT","cik":"0001812173","company_name":"Vicarious Surgical Inc.","filed_at":"2025-10-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.548835+00:00","generated_at":"2026-05-17T04:19:54.183429+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Vicarious Surgical prices $5.9M registered direct offering and private placement at $5.10/unit","bullets":["Offering comprises 1,150,000 shares (or pre-funded warrants) and Series A & B warrants for up to 2,300,000 shares at $5.10 exercise price.","Gross proceeds ~$5.9M before fees; expects to close on October 9, 2025.","Series B warrants include a call provision tied to $5.10 stock price and $100K daily volume milestones.","Common warrants exercisable only after stockholder approval; company must seek approval within 120 days of closing.","Proceeds earmarked for working capital, capex, and R&D; Lake Street Capital Markets is placement agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-097471","json":"https://secwatch.observer/filing/0001213900-25-097471.json","markdown":"https://secwatch.observer/filing/0001213900-25-097471.md","text":"https://secwatch.observer/filing/0001213900-25-097471.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812173/000121390025097471/0001213900-25-097471-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812173/000121390025097471/ea0260667-8k_vicarious.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:19:54.183429+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"34b4af38c077a66ea78e1e04475b0362fa47518b","claim":"Vicarious Surgical Inc. issued pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 561,700 shares of Common Stock of warrant to institutional investor for aggregate gross proceeds from the Offerings of approximately $5.9 million.","evidence_excerpt":"Form 8-K as the “Offerings.” The Company expects the Offerings to close on or about October 9, 2025 and to receive aggregate gross proceeds from the Offerings of approximately $5.9 million, excluding any proceeds that may be received upon the exercise of the Common Warrants and before deducting placement agent fees and other offering expenses payable by the","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390025097471/0001213900-25-097471-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 561,700 shares of Common Stock"},{"label":"Purchaser","value":"institutional investor"},{"label":"Consideration","value":"aggregate gross proceeds from the Offerings of approximately $5.9 million"}],"fact_type":"equity_issuance"},{"claim_id":"5a95f871e40564c95d7394ae71878aff5c815422","claim":"Vicarious Surgical Inc. issued Series B common warrants (the “Series B Common Warrants”) to purchase an aggregate of 1,150,000 shares of Common Stock of warrant to institutional investor for aggregate gross proceeds from the Offerings of approximately $5.9 million.","evidence_excerpt":"Form 8-K as the “Offerings.” The Company expects the Offerings to close on or about October 9, 2025 and to receive aggregate gross proceeds from the Offerings of approximately $5.9 million, excluding any proceeds that may be received upon the exercise of the Common Warrants and before deducting placement agent fees and other offering expenses payable by the","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390025097471/0001213900-25-097471-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"Series B common warrants (the “Series B Common Warrants”) to purchase an aggregate of 1,150,000 shares of Common Stock"},{"label":"Purchaser","value":"institutional investor"},{"label":"Consideration","value":"aggregate gross proceeds from the Offerings of approximately $5.9 million"}],"fact_type":"equity_issuance"},{"claim_id":"7f6e214602a37075054ad740aec7cb1dbea10bdf","claim":"Vicarious Surgical Inc. issued Series A common warrants (the “Series A Common Warrants”) to purchase an aggregate of 1,150,000 shares of Common Stock of warrant to institutional investor for aggregate gross proceeds from the Offerings of approximately $5.9 million.","evidence_excerpt":"Form 8-K as the “Offerings.” The Company expects the Offerings to close on or about October 9, 2025 and to receive aggregate gross proceeds from the Offerings of approximately $5.9 million, excluding any proceeds that may be received upon the exercise of the Common Warrants and before deducting placement agent fees and other offering expenses payable by the","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390025097471/0001213900-25-097471-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"Series A common warrants (the “Series A Common Warrants”) to purchase an aggregate of 1,150,000 shares of Common Stock"},{"label":"Purchaser","value":"institutional investor"},{"label":"Consideration","value":"aggregate gross proceeds from the Offerings of approximately $5.9 million"}],"fact_type":"equity_issuance"},{"claim_id":"a814d614b54be1a5226b6c2826d26aca0db8988d","claim":"Vicarious Surgical Inc. issued 588,300 shares of common stock to institutional investor for aggregate gross proceeds from the Offerings of approximately $5.9 million.","evidence_excerpt":"Form 8-K as the “Offerings.” The Company expects the Offerings to close on or about October 9, 2025 and to receive aggregate gross proceeds from the Offerings of approximately $5.9 million, excluding any proceeds that may be received upon the exercise of the Common Warrants and before deducting placement agent fees and other offering expenses payable by the","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390025097471/0001213900-25-097471-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"common stock"},{"label":"Shares","value":"588,300 shares"},{"label":"Purchaser","value":"institutional investor"},{"label":"Consideration","value":"aggregate gross proceeds from the Offerings of approximately $5.9 million"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}